Investing Profile

Hyung Chun

VC
Partner at Foresite Capital
foresitecapital.com/people/hy...New Haven, Connecticut
Photo of Hyung Chun, Partner at Foresite Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
Harvard University Network
598 CONNECTIONS
Stanford Center for Clinical Research (SCCR) Network
32 CONNECTIONS
cb
$2.0M - $75.0M
$38.5M
3
$668M
CompanyStageDateRound SizeTotal Raised
Indomo
SeedOct 2025$25M
$25M
Latigo Biotherapeutics
Series BMar 2025$150M
Series AFeb 2024$140M
$290M
Co-investors: Deborah Palestrant (5am Ventures), Desmond Padhi (Westlake Village BioPartners)
HHMI/NIH Research Scholar National Institutes of HealthPresent
Internal Medicine Resident Stanford Center for Clinical Research (SCCR)Present
Cardiology Fellow Stanford Center for Clinical Research (SCCR)Present
Chief Cardiology Fellow Stanford Center for Clinical Research (SCCR)Present
Assistant Professor HotmailPresent
Assistant Professor Yale University School of MedicinePresent
Associate Professor of Medicine Yale University School of MedicinePresent
Associate Professor of Medicine HotmailPresent
Associate Professor of Medicine and Pathology with Tenure HotmailPresent
Associate Professor of Medicine and Pathology with Tenure Yale University School of MedicinePresent
Co-Director, Yale Cardiovascular Research Center Yale University School of MedicinePresent
Board Observer Odyssey TherapeuticsPresent
Adjunct Associate Professor Yale University School of MedicinePresent
Board Member Latigo Biotherapeutics, Inc.Present
Adjunct Professor Stanford Center for Clinical Research (SCCR)Present
Partner Foresite CapitalPresent
Harvard University AB Biochemical Sciences